Natural killer cells and anti-tumor immunity

被引：36
|
作者：
Nicholson, Sandra E. [1 ,2 ]
Keating, Narelle [1 ,2 ]
Belz, Gabrielle T. [1 ,2 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia
[2] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia
来源：
MOLECULAR IMMUNOLOGY | 2019年 / 110卷
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
Cancer; ILCs; NK cells; IL-15; SOCS proteins; CIS; SOCS2; INNATE LYMPHOID-CELLS; SMALL-MOLECULE INHIBITOR; MOLONEY LEUKEMIA-CELLS; ROR-GAMMA-T; NK CELLS; PROGNOSTIC-SIGNIFICANCE; SH2-CONTAINING PROTEIN; CYTOTOXIC-CELLS; MICE LACKING; RECEPTOR;
D O I：
10.1016/j.molimm.2017.12.002
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Immune checkpoint inhibitors harness the power of the immune system to fight cancer. The clinical success achieved with antibodies against the inhibitory T cell receptors PD-1 and CTLA4 has focused attention on the possibility of manipulating other immune cells, in particular those involved in innate immunity. Here we review the role of innate lymphoid cells (ILCs) and their contribution to tumor immunity. As the prototypical ILC, the natural killer (NK) cell has an intrinsic ability to detect and kill cancer cells. NK cells are dependent on the cytokine interleukin (IL)-15 for their development and effector activity. We discuss the role of the Suppressor of cytokine (SOCS) proteins in negatively regulating IL-15 and NK cell responses and the potential for targeting these small intracellular regulators as new immune checkpoints.
引用
收藏
页码：40 / 47
页数：8
相关论文
共 50 条
  • [1] Dysfunctional natural killer cells can be reprogrammed to regain anti-tumor activity
    Sabag, Batel
    Puthenveetil, Abhishek
    Levy, Moria
    Joseph, Noah
    Doniger, Tirtza
    Yaron, Orly
    Karako-Lampert, Sarit
    Lazar, Itay
    Awwad, Fatima
    Ashkenazi, Shahar
    Barda-Saad, Mira
    EMBO JOURNAL, 2024, 43 (13) : 2552 - 2581
  • [2] Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity
    Dean, Isaac
    Lee, Colin Y. C.
    Tuong, Zewen K.
    Li, Zhi
    Tibbitt, Christopher A.
    Willis, Claire
    Gaspal, Fabrina
    Kennedy, Bethany C.
    Matei-Rascu, Veronika
    Fiancette, Remi
    Nordenvall, Caroline
    Lindforss, Ulrik
    Baker, Syed Murtuza
    Stockmann, Christian
    Sexl, Veronika
    Hammond, Scott A.
    Dovedi, Simon J.
    Mjoesberg, Jenny
    Hepworth, Matthew R.
    Carlesso, Gianluca
    Clatworthy, Menna R.
    Withers, David R.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] SOCS-mediated immunomodulation of natural killer cells
    Keating, Narelle
    Nicholson, Sandra E.
    CYTOKINE, 2019, 118 : 64 - 70
  • [4] The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells
    Li, Xinxin
    Dong, Wenjuan
    Nalin, Ansel P.
    Wang, Yufeng
    Pan, Pan
    Xu, Bo
    Zhang, Yibo
    Tun, Steven
    Zhang, Jianying
    Wang, Li-Shu
    He, Xiaoming
    Caligiuri, Michael A.
    Yu, Jianhua
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [5] Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy
    Min, Bokyung
    Choi, Hana
    Her, Jung Hyun
    Jung, Mi Young
    Kim, Hyo-Jin
    Jung, Mi-Young
    Lee, Eun-Kyoung
    Cho, Sung Yoo
    Hwang, Yu Kyeong
    Shin, Eui-Cheol
    IMMUNE NETWORK, 2018, 18 (04)
  • [6] Protein kinase C-θ (PKC-θ) in natural killer cell function and anti-tumor immunity
    Anel, Alberto
    Aguilo, Juan I.
    Catalan, Elena
    Garaude, Johan
    Rathore, Moeez G.
    Pardo, Julian
    Villalba, Martin
    FRONTIERS IN IMMUNOLOGY, 2012, 3
  • [7] Interleukin-15 cytokine checkpoints in natural killer cell anti-tumor immunity
    Sudholz, Harrison
    Delconte, Rebecca B.
    Huntington, Nicholas
    CURRENT OPINION IN IMMUNOLOGY, 2023, 84
  • [8] Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells
    Celia M Divino
    Shu-Hsia Chen
    Wen Yang
    Swan Thung
    Steven T Brower
    SavioLC Woo
    Breast Cancer Research and Treatment, 2000, 60 : 129 - 134
  • [9] Anti-tumor immunity induced by Interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells
    Divino, CM
    Chen, SH
    Yang, W
    Thung, S
    Brower, ST
    Woo, SLC
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 60 (02) : 129 - 134
  • [10] Preconditioning human natural killer cells with chorionic villous mesenchymal stem cells stimulates their expression of inflammatory and anti-tumor molecules
    Abumaree, M. H.
    Alshehri, N. A.
    Almotery, A.
    Al Subayyil, A. M.
    Bahattab, E.
    Abomaray, F. M.
    Khatlani, T.
    Kalionis, B.
    Jawdat, D.
    El-Muzaini, M. F.
    Al Jumah, M. A.
    AlAskar, A. S.
    STEM CELL RESEARCH & THERAPY, 2019, 10 (1)
12345